Veranova A CDMO that manages complexity with confidence

Veranova A CDMO that manages complexity with confidence

X

Digital content for Bristol Myers Squibb

BRISTOL MYERS SQUIBB

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Corporate Presentation

Corporate Presentation

VIDEO(s)

No Video

DIGITAL CONTENT

2750 News

2750 News

APIs // Active Pharmaceutical Ingredients

121 APIs, 121 USDMF, 1 KDMF, 4 NDC API

DEVELOPMENTS

294 Drug(s) in Development

294 Drug(s) in Development

DOSSIERs // Finished Dosage Formulations

1091 Dossiers, 470 FDA Orange Book, 299 Europe, 50 Canada, 199 Australia, 73 South Africa

EXCIPIENTS

5 Regulatory Filings, 5 USDMF

INSPECTIONS & REGISTRATIONS

21 FDA, 14 EDQM

Full View Screen

Full Screen View

CHARM Therapeutics Announces Collaboration with Bristol Myers Squibb

CHARM Therapeutics Announces Collaboration with Bristol Myers Squibb

BUSINESSWIRE

20 Mar 2023

Bristol Myers plots interstellar manufacturing move aboard ISS

Bristol Myers plots interstellar manufacturing move aboard ISS

FIERCE PHARMA

17 Mar 2023

BMS Announces Progress Toward Long-Term Inclusion & Diversity Goals

BMS Announces Progress Toward Long-Term Inclusion & Diversity Goals

BUSINESSWIRE

15 Mar 2023

Bristol Myers meets some diversity goals early, while missing others

Bristol Myers meets some diversity goals early, while missing others

Nicole DeFeudis ENDPTS

15 Mar 2023

Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation

Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation

REUTERS

14 Mar 2023

BMS passes on two Exscientia oncology candidates

BMS passes on two Exscientia oncology candidates

Kyle LaHucik ENDPTS

14 Mar 2023

Keytruda catches up with Opdivo in rare lung cancer type

Keytruda catches up with Opdivo in rare lung cancer type

Angus Liu FIERCE PHARMA

11 Mar 2023

Bristol Myers Squibb to Report Results for First Quarter 2023 on April 27, 2023

Bristol Myers Squibb to Report Results for First Quarter 2023 on April 27, 2023

BUSINESSWIRE

09 Mar 2023

Bristol Myers axes German launch of new cancer drug, citing pricing hurdles

Bristol Myers axes German launch of new cancer drug, citing pricing hurdles

Paul Schloesser ENDPTS

07 Mar 2023

Bristol Myers Squibb bags third indication for Reblozyl in EU

Bristol Myers Squibb bags third indication for Reblozyl in EU

BUSINESSWIRE

04 Mar 2023

biophore-india-pharmaceuticals-pvt-ltd-m-2023-03-27

Access Virtual Booth

Contact Supplier

Send me more info on How To Grow My Business Digitally?

Market Place

Home

Menu

Post Enquiry

Market Place

Search